Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: HBVTECH, L.L.C
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-09-01 to 2025-08-25
Current total value of award: $1499998.81
Description: SBIR PHASE II TOPIC 84 ENTITLED "ANTIVIRAL DRUGS TO CURE CHRONIC HEPATITIS B VIRUS INFECTION"